Skip to main content
Erwin Gelfand, MD, Pediatrics, Denver, CO

Erwin W Gelfand MD

Pediatrics•Denver, CO

Professor of Pediatrics, University Colorado

Join to View Full Profile

  • 1400 Jackson StDenver, CO 80206

  • Phone+1 303-388-4461

  • Fax+1 303-270-2174

Dr. Gelfand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Gelfand's Full ProfileAlready have an account?

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1969 - 1971
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1968 - 1969
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1966

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 1987 - 2025
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • CORE Magazine Castle Connolly, 2006
  • Elected Member The American Society for Clinical Investigation, 1980

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • The 35th Annual National Jewish Health Pulmonary and Allergy Update at Keystone 
    National Jewish Health, Keystone, Colorado - 2/6/2013

Press Mentions

  • Blockade of Histamine Receptors Suppresses Intestinal Anaphylaxis in Peanut Allergy
    Blockade of Histamine Receptors Suppresses Intestinal Anaphylaxis in Peanut AllergyNovember 15th, 2016
  • Was the Doctor Right About Your Child's Asthma Diagnosis?
    Was the Doctor Right About Your Child's Asthma Diagnosis?May 19th, 2016
  • Teva Announces FDA Approval of ProAir RespiClick® (Albuterol Sulfate) Inhalation Powder for Patients with Pediatric Asthma
    Teva Announces FDA Approval of ProAir RespiClick® (Albuterol Sulfate) Inhalation Powder for Patients with Pediatric AsthmaMay 17th, 2016
  • Join now to see all

Grant Support

  • Administrative Core ANational Heart, Lung, And Blood Institute2010–2011
  • Naturally Occurring T Regulatory Cells Control Airway HyperresponsivenessNational Institute Of Allergy And Infectious Diseases2009–2011
  • Ltb4-Blt1 Interactions In The Pathogenesis Of Allergic Airway DiseaseNational Heart, Lung, And Blood Institute2007–2011
  • Inflammation, Airways Reactivity And AsthmaNational Heart, Lung, And Blood Institute2001–2011
  • Antenatal Dietary Supplementation Is A Risk Factor For Infant Atopy Through EpigeEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2010
  • Naturally Occurring T Regulatory Cells Control Airway HyperresponsivenessNational Institute Of Allergy And Infectious Diseases2008
  • Administrative CoreNational Heart, Lung, And Blood Institute2007
  • Age-Dependent Increases In Airway Responsiveness By RSVNational Heart, Lung, And Blood Institute2004–2007
  • Role Of T Lymphocytes In Airway HyperresponsivenessNational Heart, Lung, And Blood Institute1996–2005
  • Training Program In Pediatric ImmumologyNational Institute Of Allergy And Infectious Diseases2002–2004
  • MEKK2 Regulation Of MAST Cell/T Cell Cytokine ProductionNational Institute Of Allergy And Infectious Diseases2003
  • RSV Enhances Sensitization And Airway ResponsivenessNational Heart, Lung, And Blood Institute1999–2002
  • Regulation Of MAST Cell Cytokine ProductionNational Institute Of Allergy And Infectious Diseases1998–2002
  • Mechanisms Of Steroid Reduction In IVIG Treated AsthmaNational Institute Of Allergy And Infectious Diseases1996–1997
  • Humoral And Cell-Mediated Immunity In Development Of Bronchial HyperresponsiveNational Heart, Lung, And Blood Institute1995
  • Humoral &Cell-Mediated Immunity In Development Of Bronchial HyperresponsivenessNational Heart, Lung, And Blood Institute1992–1994
  • Activation &Transformation Of Human B Cells By EB VirusNational Institute Of Allergy And Infectious Diseases1990–1992
  • Humoral And Cell-Mediated Immunity Indevelopment Of Bronchial HyperresponsivenessNational Heart, Lung, And Blood Institute1991
  • Ionic,Biochemical,Genetic Basis For Cyclosporin ActivityNational Institute Of Allergy And Infectious Diseases1989–1991

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Erwin Gelfand, Dr. Erwin Gelfand, MD, Dr. E Gelfand, Dr. Erwin W Gelfand